Related Experiment Video
Updated: May 3, 2026
An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
Antitumor effect of miR-197 targeting in p53 wild-type lung cancer
M E Fiori1, C Barbini2, T L Haas1
11] Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy [2] Regina Elena National Cancer Institute, Rome, Italy.
Abstract:
Lung cancer is the leading cause of tumor-related death. The lack of effective treatments urges the development of new therapeutic approaches able to selectively kill cancer cells. The connection between aberrant microRNA (miRNA - miR) expression and tumor progression suggests a new strategy to fight cancer by interfering with miRNA function. In this regard, LNAs (locked nucleic acids) have proven to be very promising candidates for miRNA neutralization. Here, we employed an LNA-based anti-miR library in a functional screening to identify putative oncogenic miRNAs in non-small-cell lung cancer (NSCLC). By screening NIH-H460 and A549 cells, miR-197 was identified as a new functional oncomiR, whose downregulation induces p53-dependent lung cancer cell apoptosis and impairs the capacity to establish tumor xenografts in immunodeficient mice. We further identified the two BH3-only proteins NOXA and BMF as new miR-197 targets responsible for induction of apoptosis in p53 wild-type cells, delineating miR-197 as a key survival factor in NSCLC. Thus, we propose the inhibition of miR-197 as a novel therapeutic approach against lung cancer.
Insights
Researchers identified microRNA-197 (miR-197) as a key survival factor in non-small-cell lung cancer (NSCLC). Inhibiting miR-197 triggers lung cancer cell death, offering a potential new therapy for this deadly disease.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Lung cancer remains a leading cause of cancer-related mortality globally.
- Effective targeted therapies are crucial due to limitations in current treatments.
- Aberrant microRNA (miRNA) expression is linked to tumor progression, presenting a therapeutic target.
Purpose of the Study:
- To identify novel oncogenic miRNAs in non-small-cell lung cancer (NSCLC) using a functional screening approach.
- To investigate the role of identified miRNAs in NSCLC cell survival and tumor growth.
- To explore potential therapeutic strategies targeting specific miRNAs in NSCLC.
Main Methods:
- Utilized a locked nucleic acid (LNA)-based anti-miR library for functional screening in NSCLC cell lines (NIH-H460 and A549).
- Assessed the impact of miRNA modulation on cancer cell apoptosis and tumor xenograft formation in immunodeficient mice.
- Identified direct miRNA targets using molecular assays.
Main Results:
- miR-197 was identified as a functional oncomiR in NSCLC.
- Downregulation of miR-197 induced p53-dependent apoptosis in lung cancer cells.
- NOXA and BMF were identified as direct targets of miR-197, mediating apoptosis in p53 wild-type cells.
- Inhibition of miR-197 impaired tumor xenograft establishment.
Conclusions:
- miR-197 acts as a key survival factor in NSCLC.
- Targeting miR-197 through inhibition represents a promising novel therapeutic strategy for NSCLC.
- The findings elucidate a new mechanism of cancer cell survival regulated by miR-197 and its targets.
Related Concept Videos
02:23Abnormal Proliferation
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...